Open AccessTelemedicine in French Memory Clinics During the COVID-19 Pandemic
Author(s) -
Alexandre Morin,
Thibaut Pressat-Laffouilhère,
Marie Sarazin,
Julien Lagarde,
Carole Roué-Jagot,
Pauline Olivieri,
Claire Paquet,
Emmanuel Cognat,
Julien Dumurgier,
Florence Pasquier,
Thibaut Lebouvier,
M. Ceccaldi,
Olivier Godefroy,
Olivier Martinaud,
Julien Grosjean,
Aline Zarea,
David Maltête,
David Wallon
Publication year - 2022
Publication title -
journal of alzheimer's disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-215459
Subject(s) - telemedicine , covid-19 , pandemic , dementia , medicine , emergency medicine , health care , disease , virology , outbreak , infectious disease (medical specialty) , economics , economic growth
This multicenter study was conducted in French memory clinics during the first COVID-2019 lockdown (March–May 2020). The objective was to evaluate the effect of a telemedicine consultation on treatment modification in dementia care. Among 874 patients who had a telemedicine consultation, 103 (10.7%) had treatment modifications, in particular those living with a relative or diagnosed with Alzheimer’s disease. A control group of patients referred March–May 2019 was also included. Treatment modification rate was similar between periods with an adjusted percentage difference of –4% (p = 0.27). Telemedicine consultations allowed treatment modifications with only a minor short-term negative impact on therapeutic strategies.